
|Articles|November 15, 2002
Mini shunt diverts excess aqueous humor
Green Bay, WI-The recently introduced miniature glaucoma shunt (Ex-Press) is an exciting modality with a lot of potential, but this new IOP-lowering treatment still requires further study to define its long-term efficacy and place in the armamentarium of glaucoma management options, said James E. Memmen, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
5















































.png)


